Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Tectorigenin
Cat. No.:
OB0125LY-086
Appearance:
Solid
Purity:
99.9%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
Tectorigenin is an O-methylated isoflavone that promotes osteoblast differentiation and in vivo bone healing.
Synonym:
548-77-6; 4',5,7-Trihydroxy-6-methoxyisoflavone; Tectorigenine; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-6-methoxy-4H-chromen-4-one; 4',5,7-Trihydroxy-6-methoxyisoflavone; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-6-methoxychromen-4-one; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-6-methoxy-4H-1-benzopyran-4-one; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-3-(4-hydroxyphenyl)-6-methoxy-; 5,7,4'-Trihydroxy-6-methoxyisoflavone
CAS No.:
548-77-6
Compound CID:
5281811
Formula:
C16H12O6
Formula Weight:
300.26
Specification
Relative Density:
1.512 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Tectorigenin can be used to inhibit osteoclast differentiation and bone resorption in vivo.
Library Information
Targets:
Apoptosis
Receptors:
Apoptosis inducer
Pathways:
Apoptosis
Plate Number:
AOCL-31
Plate Location:
e8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 183.2 mM
![[6]-Gingerol](https://www.obesityscientific.com/wp-content/themes/obesity/images/product/0225LY-0989.jpg)
